Jan V.
- Country
- Belgium
- Department
- Cardiology
Research Overview
- Effect of Orforglipron on Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease
- Effect of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a): A Randomized, Placebo-Controlled Study
- Evaluation of Hemodynamic Effects of Sacubitril/Valsartan in Patients with Heart Failure with Preserved Ejection Fraction and Secondary Mitral Valve Regurgitation
Data & Insights
Has run more than one trial at 485 of 1124 partner sites.
Specializations
Cardiac Function Studies
This investigator specializes in treating various forms of heart failure, with particular focus on heart failure with preserved ejection fraction and associated complications.
- Advanced heart failure management
- Secondary mitral valve regurgitation
- Cardiac hemodynamics
The research extends to innovative therapeutic approaches using combination treatments to improve cardiac outcomes.
Metabolic Disorders
The investigator conducts research in metabolic conditions affecting cardiovascular health, particularly focusing on severe hypertriglyceridemia and its treatment approaches.
- Lipid metabolism disorders
- Cardiovascular risk management
- Novel therapeutic agents
Their work encompasses evaluating new therapeutic options for patients with severe metabolic disorders.
Rare Cardiac Conditions
Expertise in treating rare cardiac disorders, specifically transthyretin amyloidosis with cardiomyopathy, investigating innovative therapeutic approaches.
- Cardiomyopathy management
- Functional capacity assessment
- Progressive cardiac conditions
The focus includes evaluation of targeted therapies for rare cardiac diseases and their impact on patient mobility.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.